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Abstract: 4 
Post-operative management of patients receiving oral biopsy includes the control of edema, pain, infection, 5 
and re-epithelization at the surgical site. This clinical study investigates the topical use of a bioadhesive gel, 6 
containing essential oils, to promote wound healing and prevent post-operative pain and infection, avoiding 7 
the need for surgical suture and chlorhexidine applications. Ten patients, who needed to receive oral biopsies 8 
(≤6 mm in diameter) for the diagnosis of mucosal oral lesions, were enrolled. The bioadhesive gel 9 
successfully controlled the post-surgical pain; at 1-week follow-up visit, no signs of infection nor side effects 10 
were reported and the surgical sites were completely healed. The bioadhesive gel resulted in a very 11 
promising agent for the post-operative management of oral biopsy site, without the need for surgical suture 12 
and chlorhexidine applications. 13 
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Introduction 17 
A mucosal biopsy is a medical procedure where a fragment (incisional biopsy) or the entire (excisional 18 
biopsy) mucosal lesion is surgically collected to establish the histopathological diagnosis. This examination 19 
is the “gold standard” in terms of diagnostic sensibility and specificity and represents a routine procedure in 20 
oral medicine (1). Under local anesthesia, a scalpel blade or a punch are usually employed to collect the 21 
tissue, and the surgical suture is often placed. The post-operative management includes the application of 22 
topical antibacterial gel, and the control of post-operative pain using non steroidal anti-inflammatory drug 23 
(NSAID), as needed by the patient. 24 
Despite a plethora of studies recognizes chlorhexidine as the gold-standard among antiseptic agents (2), this 25 
molecule is not exempted from adverse effects, most frequently represented by dental and mucosal stainings, 26 
long-lasting dysgeusia, burning sensation (3,4) and increased calculus deposition on tooth surfaces (5). Some 27 
in vitro studies also showed chlorhexidine possesses cytotoxic effects against human fibroblasts and 28 
lymphocytes, via oxidative stress pathways (6,7). Besides chlorhexidine, even the suture can be associated 29 
with complications, such as the bacterial colonization of the filaments which can occur with all type of 30 
suture, but increases while considering polyfilament, because of the micro-retaining pattern of the surface 31 
(8,9). Nonetheless, the suture often represents a source of stress and anxiety for patients. 32 
To overcome chlorhexidine and suture limitations, the alternative use of natural products, in particular 33 
originating from plants, has been widely investigated, taking advantage from their bioactivities. Among the 34 
others, essential oils (EOs) showed many biological properties, such as the antioxidant, anti-inflammatory 35 
and analgesic ones. Among plants belonging to the Myrtaceae family, the extract from Manuka 36 
(Leptospermum scoparium) has shown the capacity to reduce free radicals and antibacterial effects, as well 37 
(10). Similarly, Eucalyptus spp. displayed antioxidant, cytoprotective and antibacterial properties, too 38 
(11,12). Tea tree (Melaleuca alternifolia), another plant belonging to this family, is characterized by anti-39 
fungal (13), anti-inflammatory (14) and anti-bacterial effects (15,16). Furthermore, the extracts from the 40 
family of Lamiaceae, including Thymus vulgaris and Mentha piperita, exhibited in vitro antioxidant (17), 41 
antifungal and anti-cancer (18, 19) activities, as well as analgesic effects against inflammatory pain (20). 42 
Similar effects have been reported for Commiphora myrrha (21) and Licorice (Glycyrrhiza glabra) extracts 43 
(22). Among isolated compounds, (-)-α-bisabolol, the main component of the EO from Matricaria 44 
chamomilla, showed anti-bacterial, anti-mutagenic, anti-inflammatory, analgesic and cicatrizing properties 45 
(23,24), while anethole, from Anethum graveolens and Illicium verum, exhibited anesthetic and antioxidant 46 
effects (20,25), and decreased the synthesis and the release of several inflammatory mediators, thus 47 
explicating antinociceptive activity (26). Allantoin, physiologically present in a human body and in plants, 48 
especially in Symphytum officinale leaves, can promote wound healing and stimulate cell mitosis (27,28), 49 
displayed analgesic (29), anti-inflammatory and moisturizing effects (27), besides a certain keratolytic 50 
activity (30). 51 
A mixture of the above reported EOs and isolated phytochemicals could act in synergy to promote wound 52 
healing and show anti-inflammatory effects. Therefore, the aim of this study was to evaluate the efficacy of a 53 
topically applied bioadhesive gel, containing a mix of EOs as active ingredients, in terms of pain control and 54 
wound healing after oral biopsies. 55 
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Materials and methods 57 
 58 
Study design - This was a pilot study, as the first stage of Phase II clinical trial, non-controlled and non-59 
randomized, to preliminary investigate pain control and wound healing effects of an EOs-based bioadhesive 60 
gel (Hobagel Plus®, HOBAMA S.r.l. Milano) after oral mucosa biopsies. This study was conducted at the 61 
dental clinic of the UO Odontostomatologia II, ASST Santi Paolo e Carlo - San Paolo Hospital (University 62 
of Milan), where the interventions were performed and data collected and examined. The study included two 63 
phases: the former involved the surgical procedure and patient instructions for gel application; the latter 64 
involved the clinical follow-up visits and the recording of questionnaires.  65 
Patients recruitment - From January 2018 to February 2018, ten patients referring to the dental clinic were 66 
recruited, in full accordance with ethical principles of the World Medical Declaration of Helsinki and under 67 
the approval of local Ethics Committee (ASST Santi Paolo e Carlo). Patients were consecutively enrolled 68 
during the first visit at the oral medicine unit. Inclusion criteria were being at least 18-years old and needing 69 
excisional or incisional oral biopsies (≤6 mm in diameter) for the histopathological diagnosis of oral mucosal 70 
lesions. Exclusion criteria included uncontrolled hypertension, uncontrolled diabetes, coagulation disorders, 71 
and absolute contraindications to surgery, pregnancy, and breastfeeding. Written informed consent of each 72 
patient was signed. 73 
 74 
Personal and clinical data recording - For each patient, demographic and medical data were recorded during 75 
the first visit. An expert clinician, after having evaluated patient’s eligibility to the study, performed the 76 
intraoral examination. 77 
 78 
Intervention - Oral mucosal biopsies were carried out by trained practitioners. All surgical procedures were 79 
performed under local anesthesia, after obtaining written surgical consent. At the end of the surgical 80 
intervention, hemostasis was obtained with gauze soaked with the physiological saline solution, then, the 81 
surgical site was covered with a layer of gel (Hobagel Plus®, HOBAMA S.r.l. Milano). The gel contained 82 
Melaleuca Alternifolia Leaf Oil, Leptospermum Scoparium Branch/Leaf Oil, Ammonium Glycyrrhizate, 83 
Thymus Vulgaris Oil, Menthol, Mentha Piperita Oil, Eucalyptol, Anethole, Commiphora Myrrha Oil, 84 
Bisabolol, Tocopheryl Acetate, Allantoin, Cetylpyridinium Chloride, Hydrogen Peroxide, Sodium 85 
Hyaluronate Hydrolyzed, Sodium Hyaluronate and Triclosan as active ingredients, while Calcium/Sodium 86 
PVM/MA Copolymer, Paraffinum Liquidum, Petrolatum, Cellulose Gum, Polyvinylpyrrolidone as 87 
excipients.  88 
Each patient was instructed to apply a thin layer of gel to the surgical wound, three times a day for one week. 89 
Clinical digital photographs of the surgical site were taken, using a reflex digital camera (Nikon D5300, 85 90 
mm Micro Nikkor Af-s Lens, Metz 15 MS-1 digital Speedlight), after the biopsy and soon after topical gel 91 
application. Ordinary postoperative instructions were provided to the patient, as follows: do not disturb the 92 
area of surgery; do not spit or rinse the mouth for at least 24 hours; brush the teeth gently, taking care to not 93 
traumatize the surgical site; avoid physical activity for the first 48 hours; avoid hot/crunchy liquids or foods; 94 
if active bleeding would start, keep firm pressure by a gauze soaked with physiological saline solution for 15 95 
minutes, and, in case of persisting bleeding, apply constant pressure at the surgical site for 15 minutes using 96 
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a tranexamic acid-soaked gauze. Acetaminophen 1000 mg tablets (max. three times a day) was prescribed 97 
with the recommendation to be used just as needed. After the biopsy, the patient also received the 98 
questionnaire to be filled during the following week, which included recordings about: daily pain (using 99 
Visual Analog Scale - VAS), eventual painkillers intake, presence of edema, secondary bleeding, and 100 
possible adverse reactions to the gel. 101 
 102 
A follow-up visit was carried out one week later. Clinical photographs of the surgical site were taken again, 103 
as described above. An expert clinician (S.D.) performed the intraoral examination, particularly focused on 104 
the surgical site, recorded the presence/absence of infection or bleeding, and evaluated the wound healing in 105 
term of re-epithelization or presence of fibrin clot. 106 
 107 
Primary outcome: pain - Pain intensity was assessed by visual analog scale (VAS). VAS is structured as a 108 
100 mm horizontal line with two stop lines at the endings, which represent respectively "no pain" (left 109 
extreme) and "the worst pain conceivable" (right extreme). The patients were instructed to mark the VAS 110 
daily, always at the same hour. The VAS score was measured in millimeters, using a ruler, as the distance 111 
between and the starting point of the 100 mm line and the patient's mark (31). In accordance with Jensen et 112 
al. (32), VAS scores were further divided into four categories to quantify the postoperative pain: from 0 to 4 113 
mm = no pain, from 5 to 44 mm = mild pain, from 45 to 74 mm = moderate pain, from 75 to 100 mm = 114 
severe pain. Furthermore, the patients were instructed to record, daily, on the specific questionnaire section, 115 
the possible acetaminophen intake.  116 
 117 
Secondary outcomes: infection, bleeding, and wound healing – Since the presence of infection, persistent 118 
inflammation and bleeding can contribute to the late repair of the surgical site, all these factors were assessed 119 
by the patient day-to-day, and by the clinician at 1-week follow-up. In particular, dichotomic visual analysis 120 
(presence/absence) of bleeding and edema was recorded every day by the patients throughout specific 121 
questionnaire sections. At 1-week follow up visit, a trained clinician (S.D.) visually verified the presence of 122 
local bleeding, edema, and signs of infection, and assessed the wound healing, in term of re-epithelization or 123 
presence of fibrin clot, comparing the surgical site with previously clinical photographs. 124 
 125 
 126 
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Results 128 
 129 
Ten patients, requiring oral mucosa biopsies, participated in the study: nine females and one male (age range: 130 
44-85 years, mean± SD: 65.7±11.3 years). In four patients, multiple biopsies (n = 2) were required for the 131 
accurate histopathological diagnosis, basing on the clinical features of the mucosal lesions, 14 surgical sites 132 
were, thus, considered in this trial. Clinical data are summarized in table 1. 133 
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Table 1. Demographic and clinical data of patients enrolled in the study. *Excisional biopsy: the lesion is completely removed; incisional biopsy: a tissue 135 
fragment of the lesion is collected 136 
Patient Gender Age Site 
 
Biopsy 
Type* 
 
Multiple 
biopsies 
Adverse 
events 
 
Pain 
 
Edema Infection 
Bleeding 
 
During 
the week 
 
At 1-week 
follow up 
During 
the week 
At 1-week 
follow up 
1 male 70 hard palate incisional - none no no no none yes no 
2 female 73 
lateral surface 
of the tongue 
incisional - none mild no no none no no 
3 female 71 
mandibular 
attached 
gingiva/alveolar 
mucosa 
incisional 2 none mild no yes none no no 
7 
 
4 female 68 hard palate incisional 2 none no no no none no no 
5 female 85 hard palate incisional - none mild no no none no no 
6 female 71 
maxillary 
attached 
gingiva/alveolar 
mucosa 
incisional 2 none no no no none no no 
7 female 61 soft palate excisional - none no no no none no no 
8 female 44 
lingual aspect 
of the attached 
gingiva 
excisional - none no no no none no no 
9 female 58 
maxillary 
attached 
gingiva/alveolar 
mucosa 
incisional 2 none mild no no none no no 
10 female 56 hard palate incisional - none mild no no none yes No 
  137 
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 139 
Five biopsies were taken from the palatal mucosa and seven from the keratinized gingiva/alveolar mucosa, 140 
while in one case from the lingual margin and in a further one from the soft palate. In two patients were 141 
performed excisional biopsies as diagnostic and therapeutic procedure (excisional biopsy), while in the other 142 
ones a fragment of the lesion was removed for just diagnostic purposes (incisional biopsy). 143 
In all case, the EOs-based gel showed high and long-lasting bioadhesion, remaining in place for several 144 
minutes after a single application. 145 
Primary outcome: pain - During the week following the procedure, each patient was asked to record daily 146 
the level of pain using VAS, the presence/absence of secondary bleeding, the presence/absence of edema, 147 
painkillers use and experience of adverse reactions to the gel. In five cases, a mild level of pain was reported: 148 
3 of them recorded mild pain just during the day of the intervention (patients number 3, 9, and 10 – Table 1), 149 
another one exclusively during eating and speaking, and the pain lasted for the following four days (patient 150 
number 2 – Table 1), a further patient reported mild pain when wearing the denture. In the latter case, a 151 
double biopsy was performed at the hard palate, localized exactly on the mucosa under denture bases (patient 152 
number 5 - Table 1). The remaining five patients reported no pain during the week after surgery. After the 153 
fifth day, all patients did not record any pain.  154 
Mean VAS values, recorded each day after the biopsy for one week, are shown in Figure 2. Overall, a mild 155 
pain resulted during the same day of the intervention (day 0), while from postoperative day 1 to day 6 no 156 
pain was recorded. None of the patients reported the use of acetaminophen or other painkillers. 157 
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 158 
Figure 2. Distribution of daily means VAS score. 159 
 160 
Secondary outcomes: infection, bleeding, and wound healing – The gel, placed after gauze compression on 161 
the surgical site, successfully controlled post-operative bleeding in all patients (Fig. 1a and b). Only one 162 
patient reported a light edema at the surgical site soon after the biopsy, which resolved within the first 2 days 163 
(patient number 3 – Table 1). 164 
In terms of secondary bleeding, two patients reported one episode during the first day: one of them occurred 165 
two hours after the surgery, while the patient was eating, and was easily controlled by the compression of the 166 
site with saline impregnated gauze (patient number 1 – Table 1). The other case of secondary bleeding 167 
occurred after the patient had performed physical activity and taken his dinner, thus largely increased the risk 168 
of this complication. The same patient controlled the bleeding using tranexamic acid-soaked gauze, instead 169 
of a saline one as we recommended (patient number 10 – Table 1). 170 
None of the patients enrolled reported adverse events to the gel. 171 
 172 
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At 1-week follow-up visit, no signs of infection at the surgical sites could be observed (Figure 1c). In 10 173 
surgical sites, complete or partial re-epithelization occurred, in other 4 the presence of fibrin clot could be 174 
detected (Figure 1c, as an example). 175 
 176 
Figure 1. Intraoral photographs: a) surgical site, b) wound covered by a thin layer of gel, c) clinical 177 
appearance of the surgical site at 1-week follow up. 178 
 179 
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Discussion 181 
The need of new agents as alternatives to surgical suture and chlorhexidine is still demanding, and, in recent 182 
decades, high attention has been directed towards several plant-derived compounds with antiseptic, anti-183 
inflammatory and wound healing properties. The role of chlorhexidine application over the suture is to 184 
reduce bacterial colonization of filaments (9,33), usually associated with both aerobic (Streptococcus spp., 185 
Staphylococcus warneri, Neisseria spp., Actinomyces spp., Pasteurella spp.) and anaerobic (Veillonella 186 
parvula, Peptostreptococcus spp., Actinobacillus spp., Prevotella spp., Fusobacterium spp.) microorganisms. 187 
Chlorhexidine, however, has the major drawbacks to stain oral hard and soft tissue and to modify the 188 
perception of taste (34,35). Recently, Vouzara and colleagues (36) demonstrated its cytotoxicity, which 189 
resulted significantly higher than sodium hypochlorite and ethylenediaminetetraacetic acid. Hidalgo et al. (6) 190 
found that chlorhexidine produced mitochondrial injury and had anti-proliferative effects against human 191 
fibroblasts, consistently with Salimi and colleagues (7) who demonstrated its cytotoxicity in human 192 
lymphocytes. 193 
This pilot study demonstrated the promising effects of a high bioadhesive gel containing a mixture of EOs in 194 
controlling post-operative inflammation and wound healing after minor surgery, i.e. oral mucosal biopsies. 195 
Noteworthy, just two patients out ten reported a mild pain up to three days from intervention, three patients 196 
reported mild pain just for one day, while, in the remaining 5, no pain was ever perceived. This finding was 197 
consistent with the findings reported by Kearns and Lodi (37,38). Interestingly, none of the patients, in this 198 
study, declared the use of painkillers after the intervention. This finding indicates a better outcome than data 199 
available from the literature, which reports about 18-26% of patients taking painkillers after oral mucosa 200 
biopsies, usually during the same day of surgery (38,39). One week later, 10 surgical sites experienced 201 
partial or complete re-epithelization, while the remaining ones had a stable fibrin clot; in all cases, no signs 202 
of infection were detectable. Interestingly, partial or complete re-epithelization of surgical wounds occurred 203 
in five patients out six who were affected by immune-mediated inflammatory oral mucosal diseases (oral 204 
lichenoid lesions, mucous membrane pemphigoid, and oral lichen planus).  205 
All these findings might be ascribed to the strong bioadhesion of the gel and to the synergic effects of its 206 
active ingredients. The Manuka EO, indeed, possesses high antioxidant and antibacterial properties, even 207 
against Methicillin-Resistant Staphylococcus Aureus (MRSA) (39), besides anti-inflammatory activity, 208 
reducing migration of inflammatory cells at the wound site and stimulating the proliferation of fibroblasts 209 
and epithelial cells (10). Similarly, to Manuka EO, Thymus vulgaris and Melaleuca alternifolia EOs showed 210 
high antibacterial and antioxidant properties (16, 18). Terpinen-4-ol, a component of many EOs, is one of the 211 
most investigated compounds and evidence suggests that it can suppress inflammatory mediators by 212 
monocytes, and reduce histamine-induced skin inflammation (40,41). Nogueira (14) investigated the 213 
capacity of terpinen-4-ol and α-terpineol (another EO constituent) to modulate macrophage response towards 214 
bacterial stimulation and found that these compounds significantly reduce the production of several 215 
interleukins (IL-1β, IL-6, IL-8, and IL-10). Furthermore, EO from Mentha piperita, mainly composed by 216 
menthol, exhibited anti-inflammatory properties, too, as shown in animal models, by inhibiting the 217 
production of nitric oxide and prostaglandin E2 in lipopolysaccharide-activated macrophages (42). A review 218 
by de Cassia (20) reported, in particular, a significant analgesic activity of menthol in controlling acute and 219 
inflammatory pain. This could act in combination with both (-)-α-bisabolol (24), Commiphora myrrha (21), 220 
allantoin (20), anethole and licorice (27,43), which display analgesic activity together with anti-inflammatory 221 
and wound healing effects.  222 
No adverse events were found. One case of post-operative swelling occurred in a patient affected by a 223 
chronic inflammatory oral disease (oral lichen planus), which could have exacerbated the response to 224 
surgical trauma. Just two cases of minor the secondary bleeding, during the same day of the intervention, 225 
were reported, but they could be explained since patients disobeyed the post-surgical instructions provided 226 
by the clinician. Indeed, one patient reported that the bleeding occurred while he was eating crunchy food in 227 
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the same day of surgery, while the second one carried out intense physical activity, and, again, the bleeding 228 
occurred while eating.  229 
Within the limitations of this pilot study (having little sample size and following a not controlled and not 230 
randomized design), the here proposed EOs-based bioadhesive gel may represent a promising alternative to 231 
the use of suture and chlorhexidine, promoting wound healing, showing anti-inflammatory effects, and 232 
reducing operative time, patient distress, and chlorhexidine side effects as well. It may be particularly useful 233 
in those cases difficult to suture (for example gingiva and hard palate mucosa), or in presence of highly 234 
inflamed and friable tissue. The further second stage of this Phase II clinical trial is needed to better explore 235 
these preliminary findings, especially throughout the controlled randomized clinical trial on large patient 236 
population. 237 
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